Rising incidences of cancer owing to unhealthy food habits and sedentary lifestyle coupled with the growing technological advancements has resulted in the growth of global cancer diagnostics market
Market for cancer diagnostics is growing at a steady pace due to higher incidences of cancer among the population, where emerging markets are expected to achieve higher growth.
Given the growing demand for early detection of cancer, tumor marker tests are gaining prominence and are projected to witness stronger growth in the coming years.
Growth in the incidences of cancer across the globe is due to the sedentary lifestyle such as increasing tobacco consumption and unhealthy eating habits.
Advancement in genomics has resulted in the growing cancer research, due to which early detection of cancer is gaining popularity.
Global Cancer Diagnostics Market is forecasted to grow at a CAGR of 8.8% during 2016 – 2021F, on account of rising incidences of cancer globally, along with the increasing technological advancement driven by focus on cancer research
North America region remains the major market followed by Europe in the actual period. In the forecast period, APAC region will witness strong growth driven by countries such as India and China.
According to Azoth Analytics research report, Global Cancer Diagnostics Market: Trends, Opportunities and Forecasts (2016-2021), Global Cancer Diagnostics market is projected to exhibit a CAGR of over ~8.8% during 2016 - 2021. On the basis of market segment, Global Cancer Diagnostics Market has been segmented by type (By Type: Imaging Tests, Endoscopy, Biopsy and Tumor Marker, By Imaging Tests Sub-Type: MRI, Ultrasound, PET-CT Scan, Mammography, By Region: North America, Latin America, APAC, Europe and MEA.)
Scope of the Report
The report provides Segmentation by Type
•Imaging Tests
•Endoscopy
•Biopsy
•Tumor Marker
The report provides Segmentation by Sub- Type
•Imaging Tests : MRI, Ultrasound, PET-CT Scan, Mammography
The report provides coverage by Region
•North America
•Europe
•Asia Pacific
•Latin America
•Middle East and Africa (MEA)
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
3.1. North America and Europe to drive the Cancer Diagnostic Market
3.2. Lung, Breast, Bowel and Prostrate Cancers to remain the major cause of Cancer Diagnostics
3.3. Cancer Imaging Test would form the largest market segment for Cancer Diagnosis
4. Global Cancer Diagnostics Market: An Overview
4.1. Product Overview
4.1.1.Global Cancer Diagnostics Market, By Value 2011-2015
4.1.2.Global Cancer Diagnostics Market, By Value 2016-2021F
Global Cancer Diagnostics Market: By Type (Imaging Tests, Endoscopy, Biopsy, Tumour Marker Tests)
4.1. Global Imaging Tests Market
4.1.1.By Value (Historic 2011-15)
4.1.2.By Value (Forecast 2016E-2021F)
4.1.3.By Sub-Type - Ultrasound, PET-CT Scan, Mammography, MRI (By Value 2016E-2021F)
4.2. Global Endoscopy Cancer Diagnostics Market
4.2.1.By Value (Historic 2011-15)
4.2.2.By Value (Forecast 2016E-2021F)
4.3. Global Biopsy Market
4.3.1.By Value (Historic 2011-15)
4.3.2.By Value (Forecast 2016E-2021F)
4.4. Global Tumour Marker Tests Market
4.4.1.By Value (Historic 2011-15)
4.4.2.By Value (Forecast 2016E-2021F)
4.5. Global Imaging Test Market, By Region, By Value (2016E-2021F)
5. North America Cancer Diagnostics Market: An Overview
5.1. North America Cancer Diagnostics Market
5.1.1.By Value (Historic 2011-15)
5.1.2.By Value (Forecast 2016E-2021F)
5.2. North America Cancer Diagnostics Country Overview – USA, Canada
6. APAC Cancer Diagnostics Market: An Overview
6.1. APAC Cancer Diagnostics Market
6.1.1.By Value (Historic 2011-15)
6.1.2.By Value (Forecast 2016E-2021F)
6.2. APAC Cancer Diagnostics Country Overview – India, China
7. Europe Cancer Diagnostics Market: An Overview
7.1. Europe Cancer Diagnostics Market
7.1.1.By Value (Historic 2011-15)
7.1.2.By Value (Forecast 2016E-2021F)
7.2. Europe Cancer Diagnostics Country Overview –Denmark, UK
8. Latin America Cancer Diagnostics Market: An Overview
8.1. Latin America Cancer Diagnostics Market
8.1.1.By Value (Historic 2011-15)
8.1.2.By Value (Forecast 2016E-2021F)
8.2. Latin America Cancer Diagnostics Country Overview – Chile, Brazil
9. MEA Cancer Diagnostics Market: An Overview
9.1. MEA Cancer Diagnostics Market
9.1.1.By Value (Historic 2011-15)
9.1.2.By Value (Forecast 2016E-2021F)
9.2. MEA Cancer Diagnostics Country Overview – UAE
10. Market Dynamics
10.1. Market Trends & Developments
10.2. Market Drivers
10.3. Challenges
11. Policy Regulations
12. SWOT Analysis
13. Porter Five Force Model
14. Company Profiling
14.1. Abbott Laboratories
14.2. Becton Dickinson and Company
14.3. F. Hoffmann-La Roche AG (Roche Diagnostics)
14.4. General Electric Co (General Healthcare)
14.5. Thermo Fisher Scientific
14.6. Agilent Technologies, Inc.
14.7. Illumina, Inc.
14.8. Hologic Inc.
14.9. C. R. Bard Inc.
15 About us & Disclaimer
Research Methodology
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.